JP2015529211A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529211A5
JP2015529211A5 JP2015530374A JP2015530374A JP2015529211A5 JP 2015529211 A5 JP2015529211 A5 JP 2015529211A5 JP 2015530374 A JP2015530374 A JP 2015530374A JP 2015530374 A JP2015530374 A JP 2015530374A JP 2015529211 A5 JP2015529211 A5 JP 2015529211A5
Authority
JP
Japan
Prior art keywords
fusion polypeptide
sample
analyte
skp
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015530374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015529211A (ja
JP6285934B2 (ja
Filing date
Publication date
Priority claimed from EP12006298.9A external-priority patent/EP2706115A1/en
Application filed filed Critical
Publication of JP2015529211A publication Critical patent/JP2015529211A/ja
Publication of JP2015529211A5 publication Critical patent/JP2015529211A5/ja
Application granted granted Critical
Publication of JP6285934B2 publication Critical patent/JP6285934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015530374A 2012-09-06 2013-09-04 イムノアッセイの干渉の低減、及び安定化のためのシャペロン−シャペロン融合ポリペプチド Active JP6285934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12006298.9A EP2706115A1 (en) 2012-09-06 2012-09-06 Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
EP12006298.9 2012-09-06
PCT/EP2013/068269 WO2014037389A1 (en) 2012-09-06 2013-09-04 Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays

Publications (3)

Publication Number Publication Date
JP2015529211A JP2015529211A (ja) 2015-10-05
JP2015529211A5 true JP2015529211A5 (enExample) 2016-09-15
JP6285934B2 JP6285934B2 (ja) 2018-02-28

Family

ID=46963361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015530374A Active JP6285934B2 (ja) 2012-09-06 2013-09-04 イムノアッセイの干渉の低減、及び安定化のためのシャペロン−シャペロン融合ポリペプチド

Country Status (6)

Country Link
US (1) US10197559B2 (enExample)
EP (2) EP2706115A1 (enExample)
JP (1) JP6285934B2 (enExample)
CN (1) CN104583408B (enExample)
CA (1) CA2881411C (enExample)
WO (1) WO2014037389A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018017336A2 (pt) 2016-03-07 2018-12-26 Hoffmann La Roche método in vitro para detectar um anticorpo para p53 (anticorpo anti-p53) em uma amostra e polipeptídeo de fusão
ES2961462T3 (es) * 2017-07-27 2024-03-12 Roche Diagnostics Gmbh Proteína de fusión multiepítopo de un antígeno del VHC y usos de la misma
JP7654240B2 (ja) 2017-09-19 2025-04-01 マサチューセッツ インスティテュート オブ テクノロジー キメラ抗原受容体t細胞治療のための組成物およびその使用
EP4139684A1 (en) 2020-04-23 2023-03-01 F. Hoffmann-La Roche AG Corona nucleocapsid antigen for use in antibody-immunoassays
US20250298022A1 (en) 2022-05-03 2025-09-25 Roche Diagnostics Operations, Inc. Hiv gp41 variants for immunodiagnostic assays
WO2025098623A1 (en) 2023-11-09 2025-05-15 Roche Diagnostics Gmbh Transglutaminase substrates for labeling

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100702373B1 (ko) 2001-06-22 2007-04-02 에프. 호프만-라 로슈 아게 레트로바이러스 표면 당단백질을 함유하는 가용성 복합체
EP1971684B1 (en) 2006-01-03 2011-10-05 Roche Diagnostics GmbH Chimaeric fusion protein with superior chaperone and folding activities
ATE529436T1 (de) * 2007-04-20 2011-11-15 Hoffmann La Roche Erkennung von primären infektionen mit krankheitserregern
CA2705716C (en) 2007-12-13 2013-03-19 F. Hoffmann-La Roche Ag Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies
EP2127678A1 (en) * 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology

Similar Documents

Publication Publication Date Title
JP2015529211A5 (enExample)
JP2016511417A5 (enExample)
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
SG10201906750XA (en) Assays for detecting the presence or amount of an anti-drug antibody
JP2016528236A5 (enExample)
MX2015012824A (es) Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
WO2008027942A3 (en) Combination hepatitis c virus antigen and antibody detection method
JO3812B1 (ar) أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1)
JP2009284902A5 (enExample)
ZA202002415B (en) Detection of symmetrical dimethylarginine
MX2017011489A (es) Detección de moléculas pequeñas mediante nanoporos a través de ensayos de competición.
BR112015022844A8 (pt) método para determinar a presença ou ausência de anticorpos específicos do doador em uma amostra biológica, sistema e kit para praticar o mesmo
Ngubane et al. High-throughput sequencing enhanced phage display identifies peptides that bind mycobacteria
EA201892325A1 (ru) Композиции и способы детектирования белков клетки-хозяина
JP2017536846A5 (enExample)
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
JP2013174612A5 (enExample)
JP2016528486A5 (enExample)
WO2018068064A3 (en) Mycobacterium tuberculosis proteins in diagnostic assays and devices for tuberculosis detection and diagnosis
JP2014524583A5 (enExample)
CN104650185A (zh) 一条与猪瘟e0蛋白相结合的多肽序列及其应用
WO2015128394A3 (en) Soluble and immunoreactive variants of htlv capsid antigen p24
JP2017512200A5 (enExample)
WO2016069762A3 (en) Subject anti-hcv antibody detection assays employing ns3 capture peptides
JP2017037014A5 (enExample)